Hideki Endoh

9.9k citations

54 papers · 7.6k indexed · 4 hit papers · h-index 23

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies

Papers in ⓘ

Pulmonary and Respiratory Medicine 23
- Lung Cancer Treatments and Mutations 13
- Metastasis and carcinoma case studies 5
- Lung Cancer Diagnosis and Treatment 4
Oncology 16
- HER2/EGFR in Cancer Research 6
- Cytokine Signaling Pathways and Interactions 4

Co-authors: Tetsuya Mitsudomi (12 shared papers)Yasushi Yatabe (11 shared papers)Takashi Takahashi (5 shared papers)Takayuki Kosaka (12 shared papers)Hiroyuki Kuwano (13 shared papers)Shigeaki Kato (7 shared papers)Hiroyuki Kawashima (4 shared papers)Shuta Tomida (2 shared papers)
Journals: Cancer Research (3 papers)FEBS Letters (3 papers)Journal of Clinical Oncology (3 papers)Journal of Thoracic Oncology (2 papers)Lung Cancer (2 papers)
Partner nations: Japan United States Norway

In The Last Decade

Hideki Endoh

52 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence 2005 · 830 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Journal of Clinical Oncology
2004 Cancer Research
2004 Cancer Research
1995 Science

Peers

Countries citing papers authored by Hideki Endoh

Since Specialization

Citations

This map shows the geographic impact of Hideki Endoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Endoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Endoh more than expected).

Fields of papers citing papers by Hideki Endoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Endoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Endoh. The network helps show where Hideki Endoh may publish in the future.

Co-authors

The 25 scholars most cited alongside Hideki Endoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Endoh Line = papers co-authored together Hideki Endoh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reduced Expression of the *let-7* MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival Cancer Research ·Junichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa, Shuta Tomida, Hirotaka Osada, Hideki Endoh, Tomoko Harano, Yasushi Yatabe, Masato Nagino, Yuji Nimura, Tetsuya Mitsudomi, Takashi Takahashi Hit paper breakdown →	2004	1938
2	Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase Science ·Shigeaki Kato, Hideki Endoh, Yoshikazu Masuhiro, Takuya Kitamoto, Shimami Uchiyama, Haruna Sasaki, Shoichi Masushige, Yukiko Gotoh, Eisuke Nishida, Hiroyuki Kawashima, Daniel Metzger, Pierre Chambon Hit paper breakdown →	1995	1616
3	Mutations of the *Epidermal Growth Factor Receptor* Gene in Lung Cancer Cancer Research ·Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi Hit paper breakdown →	2004	1036
4	Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence Journal of Clinical Oncology ·Tetsuya Mitsudomi, Takayuki Kosaka, Hideki Endoh, Yoshitsugu Horio, Toyoaki Hida, Shoichi Mori, Shunzo Hatooka, Masayuki Shinoda, Takashi Takahashi, Yasushi Yatabe Hit paper breakdown →	2005	830
5	Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib Clinical Cancer Research ·Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Kimihide Yoshida, Toyoaki Hida, Masahiro Tsuboi, Hirohito Tada, Hiroyuki Kuwano, Tetsuya Mitsudomi	2006	480
6	Rapid Activation of MAP Kinase by Estrogen in the Bone Cell Line Biochemical and Biophysical Research Communications ·Hideki Endoh, Haruna Sasaki, Kazunori Maruyama, Ken-ichi Takeyama, Iwao Waga, Takao Shimizu, Shigeaki Kato, Hiroyuki Kawashima	1997	196
7	Selective Interaction of Vitamin D Receptor with Transcriptional Coactivators by a Vitamin D Analog Molecular and Cellular Biology ·Ken‐ichi Takeyama, Yoshikazu Masuhiro, Hiroaki Fuse, Hideki Endoh, Akiko Murayama, Sachiko Kitanaka, Miyuki Suzawa, Junn Yanagisawa, Shigeaki Kato	1999	153
8	Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction Journal of Clinical Oncology ·Hideki Endoh, Shuta Tomida, Yasushi Yatabe, Hiroyuki Konishi, Hirotaka Osada, Kohei Tajima, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi	2004	136
9	A Novel Isoform of Rat Estrogen Receptor Beta with 18 Amino Acid Insertion in the Ligand Binding Domain as a Putative Dominant Negative Regulator of Estrogen Action Biochemical and Biophysical Research Communications ·Kazunori Maruyama, Hideki Endoh, Haruna Sasaki-Iwaoka, Hiroyuki Kanou, Eiko Shimaya, Seiichi Hashimoto, Shigeaki Kato, Hiroyuki Kawashima	1998	118
10	Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers Lung Cancer ·Kenji Tomizawa, Kenichi Suda, Ryoichi Onozato, Takayuki Kosaka, Hideki Endoh, Yoshitaka Sekido, Hisayuki Shigematsu, Hiroyuki Kuwano, Yasushi Yatabe, Tetsuya Mitsudomi	2011	113
11	Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein Genes & Development ·Tetsuro Yahata, Wenlin Shao, Hideki Endoh, Jingyung Hur, Kathryn R. Coser, Huiping Sun, Yoshitaka Ueda, Shigeaki Kato, Kurt J. Isselbacher, Myles Brown, Toshi Shioda	2001	104
12	Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors Cancer Research ·Takayuki Kosaka, Junko Tanizaki, Raymond M. Paranal, Hideki Endoh, Christine Lydon, Marzia Capelletti, Claire E. Repellin, Jihyun Choi, Atsuko Ogino, Antonio Calles, Dalia Ercan, Amanda J. Redig, Magda Bahcall, Geoffrey R. Oxnard, Michael J. Eck, Pasi A. Jänne	2017	100
13	Molecular mechanism of a cross‐talk between oestrogen and growth factor signalling pathways Genes to Cells ·Shigeaki Kato, Yoshikazu Masuhiro, Michiko Watanabe, Yôko Kobayashi, Ken‐ichi Takeyama, Hideki Endoh, Junn Yanagisawa	2000	94
14	PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients Journal of Thoracic Oncology ·Hideki Endoh, Yasushi Yatabe, Takayuki Kosaka, Hiroyuki Kuwano, Tetsuya Mitsudomi	2006	71
15	Prospects for drug screening using the reverse two-hybrid system Trends in biotechnology ·Marc Vidal, Hideki Endoh	1999	66
16	Exon—intron organization of the Arabidopsis thaliana protein kinase genes CDC2a and CDC2b FEBS Letters ·Yoshiro Imajuku, Takashi Hirayama, Hideki Endoh, Atsuhiro Oka	1992	61
17	RASSF1A gene inactivation in non‐small cell lung cancer and its clinical implication International Journal of Cancer ·Hideki Endoh, Yasushi Yatabe, Shigeki Shimizu, Kohei Tajima, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi	2003	55
18	FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs Molecular Cancer Research ·Takehiko Yokobori, Yozo Yokoyama, Akira Mogi, Hideki Endoh, Bolag Altan, Takayuki Kosaka, Ei Yamaki, Toshiki Yajima, Kenji Tomizawa, Yoko Azuma, Ryoichi Onozato, Tatsuya Miyazaki, Shigebumi Tanaka, Hiroyuki Kuwano	2013	47
19	PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients Journal of Thoracic Oncology ·Hideki Endoh, Yasushi Yatabe, Takayuki Kosaka, Hiroyuki Kuwano, Tetsuya Mitsudomi	2006	36
20	Risk analysis of pulmonary resection for elderly patients with lung cancer Surgery Today ·Hideki Endoh, Ryohei Yamamoto, Yukitoshi Satoh, Hiroyuki Kuwano, Nobuhiro Nishizawa	2012	29

About Hideki Endoh

Hideki Endoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Aging, Biotechnology and Dermatology, having authored 54 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (6 papers), Metastasis and carcinoma case studies (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Plant tissue culture and regeneration (4 papers), Transgenic Plants and Applications (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.8k citations), Genetics (1.7k citations) and Molecular Biology (4.2k citations). Hideki Endoh has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Tetsuya Mitsudomi, Yasushi Yatabe, Takashi Takahashi, Takayuki Kosaka, Hiroyuki Kuwano, Shigeaki Kato, Hiroyuki Kawashima, Shuta Tomida, Hiroyuki Konishi and Yoshikazu Masuhiro. Their work appears in journals such as Cancer Research, FEBS Letters, Journal of Clinical Oncology, Journal of Thoracic Oncology and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact